Skip to main content

Compare Stocks

Date Range: 

 AtrionMiMedx GroupSI-BONETactile Systems TechnologyCerus
SymbolNASDAQ:ATRINASDAQ:MDXGNASDAQ:SIBNNASDAQ:TCMDNASDAQ:CERS
Price Information
Current Price$614.99$9.23$32.81$52.92$5.97
52 Week RangeN/ABuyBuyBuyBuy
MarketRank™
Overall Score1.11.71.51.41.7
Analysis Score0.03.52.52.33.5
Community Score2.25.02.52.82.9
Dividend Score1.70.00.00.00.0
Ownership Score0.80.01.70.01.7
Earnings & Valuation Score0.60.00.61.90.6
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$20.00$38.43$59.00$8.50
% Upside from Price TargetN/A116.68% upside17.12% upside11.49% upside42.38% upside
Trade Information
Market Cap$1.11 billion$1.03 billion$1.03 billion$1.03 billion$990.23 million
Beta0.131.711.411.691.37
Average Volume7,507550,914283,597156,7512,142,526
Sales & Book Value
Annual Revenue$155.07 million$299.26 million$67.30 million$189.49 million$74.65 million
Price / Sales7.253.4516.005.4913.69
Cashflow$21.51 per shareN/AN/A$0.78 per shareN/A
Price / Cash28.59N/AN/A68.21N/A
Book Value$128.24 per share$0.31 per share$2.52 per share$5.92 per share$0.41 per share
Price / Book4.8029.7713.028.9414.56
Profitability
Net Income$36.76 million$-25,580,000.00$-38,400,000.00$10.97 million$-71,240,000.00
EPSN/AN/A($1.55)$0.56($0.51)
Trailing P/E Ratio34.65N/AN/AN/AN/A
Forward P/E RatioN/A160.36N/A
P/E GrowthN/AN/AN/A10.36N/A
Net Margins21.90%-37.28%-61.67%-4.57%-73.72%
Return on Equity (ROE)13.90%-404.08%-45.03%1.37%-63.47%
Return on Assets (ROA)12.55%-58.81%-29.29%0.99%-30.82%
Dividend
Annual Payout$7.00N/AN/AN/AN/A
Dividend Yield1.14%N/AN/AN/AN/A
Three-Year Dividend Growth46.67%N/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend Growth17 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A3.70%0.39%N/A0.36%
Current Ratio8.91%2.99%12.65%4.45%3.84%
Quick Ratio5.08%2.80%12.22%3.58%3.42%
Ownership Information
Institutional Ownership Percentage63.17%4.03%65.26%N/A82.06%
Insider Ownership Percentage22.44%19.80%15.50%5.30%6.49%
Miscellaneous
Employees636735295707254
Shares Outstanding1.83 million111.93 million32.81 million19.65 million171.17 million
Next Earnings Date8/5/2021 (Estimated)8/3/2021 (Estimated)8/2/2021 (Estimated)8/2/2021 (Estimated)8/3/2021 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Cerus (NASDAQ:CERS) Issues FY 2021 Earnings GuidanceCerus (NASDAQ:CERS) Issues FY 2021 Earnings Guidance
americanbankingnews.com - May 18 at 10:48 AM
Other news to note for May 17, 2021 | 2021-05-17 - BioWorld OnlineOther news to note for May 17, 2021 | 2021-05-17 - BioWorld Online
bioworld.com - May 17 at 7:26 PM
Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - BioSpaceCerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - BioSpace
biospace.com - May 17 at 7:26 PM
Comprehensive Report on Apheresis Machines Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 | Kaneka Corporation, Cerus Corporation, Kawasumi Laboratories Inc., Haemonetics Corporation – Test & Measurement - Test & MeasurementComprehensive Report on Apheresis Machines Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 | Kaneka Corporation, Cerus Corporation, Kawasumi Laboratories Inc., Haemonetics Corporation – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 17 at 9:25 AM
Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - Yahoo FinanceCerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - Yahoo Finance
finance.yahoo.com - May 17 at 9:25 AM
Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for PlateletsCerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets
finance.yahoo.com - May 17 at 9:25 AM
Zika Vaccines Sales Market 2021 Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand, Analysis By Top Leading Player And Forecast Till 2027| Bharat Biotech, Inovio Pharmaceuticals, Cerus Corporation – Test & Measurement - Test & MeasurementZika Vaccines Sales Market 2021 Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand, Analysis By Top Leading Player And Forecast Till 2027| Bharat Biotech, Inovio Pharmaceuticals, Cerus Corporation – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 14 at 8:16 AM
Blood Purification Equipment Market to Witness Huge Growth by 2027 | Cerus Corp Company, Aethlon Medical Inc, Spectral Medical Inc – Clark County Blog - Clark County BlogBlood Purification Equipment Market to Witness Huge Growth by 2027 | Cerus Corp Company, Aethlon Medical Inc, Spectral Medical Inc – Clark County Blog - Clark County Blog
clarkcountyblog.com - May 13 at 5:48 PM
Cerus (NASDAQ:CERS) Releases FY 2021 Earnings GuidanceCerus (NASDAQ:CERS) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 11 at 8:54 AM
Massive Growth of Apheresis Market by 2026 | Cerus Corporation, Fresenius Se & Co. Kgaa, Asahi Kasei Medical Co., Ltd. (A Subsidiary Of Asa, Haemonetics Corporation, Terumo Bct – Brockville Observer - Brockville ObserverMassive Growth of Apheresis Market by 2026 | Cerus Corporation, Fresenius Se & Co. Kgaa, Asahi Kasei Medical Co., Ltd. (A Subsidiary Of Asa, Haemonetics Corporation, Terumo Bct – Brockville Observer - Brockville Observer
thebrockvilleobserver.ca - May 11 at 12:03 AM
Cerus: Q1 Earnings SnapshotCerus: Q1 Earnings Snapshot
myrtlebeachonline.com - May 8 at 2:06 PM
Analysts Offer Insights on Healthcare Companies: Cerus (CERS), EyePoint Pharmaceuticals (EYPT) and Arbutus Biopharma (ABUS) - Smarter AnalystAnalysts Offer Insights on Healthcare Companies: Cerus (CERS), EyePoint Pharmaceuticals (EYPT) and Arbutus Biopharma (ABUS) - Smarter Analyst
smarteranalyst.com - May 6 at 12:57 PM
Cerus (NASDAQ:CERS) Announces Quarterly  Earnings ResultsCerus (NASDAQ:CERS) Announces Quarterly Earnings Results
americanbankingnews.com - May 5 at 7:01 PM
Cerus (NASDAQ:CERS) Shares Up 9.3%Cerus (NASDAQ:CERS) Shares Up 9.3%
americanbankingnews.com - May 5 at 12:26 PM
Cerus Corporation (CERS) CEO Obi Greenman on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaCerus Corporation (CERS) CEO Obi Greenman on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 5 at 11:49 AM
Should You Buy Cerus Corporation (CERS) Stock After it Is Down 4.52% in a Week? - InvestorsObserverShould You Buy Cerus Corporation (CERS) Stock After it Is Down 4.52% in a Week? - InvestorsObserver
investorsobserver.com - May 5 at 11:49 AM
Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript - Motley FoolCerus Corporation (CERS) Q1 2021 Earnings Call Transcript - Motley Fool
fool.com - May 5 at 11:49 AM
Cerus: Q1 Earnings Snapshot - Miami HeraldCerus: Q1 Earnings Snapshot - Miami Herald
miamiherald.com - May 5 at 11:49 AM
Cerus Corporation (CERS) Q1 2021 Earnings Call TranscriptCerus Corporation (CERS) Q1 2021 Earnings Call Transcript
fool.com - May 5 at 9:44 AM
Cerus Target of Unusually High Options Trading (NASDAQ:CERS)Cerus Target of Unusually High Options Trading (NASDAQ:CERS)
americanbankingnews.com - May 5 at 6:58 AM
Cerus: Q1 Earnings Snapshot - The Edwardsville IntelligencerCerus: Q1 Earnings Snapshot - The Edwardsville Intelligencer
theintelligencer.com - May 4 at 11:55 PM
Cerus Corp. to Host Earnings Call - Yahoo FinanceCerus Corp. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - May 4 at 6:54 PM
Cerus: Q1 Earnings Snapshot - Beaumont EnterpriseCerus: Q1 Earnings Snapshot - Beaumont Enterprise
beaumontenterprise.com - May 4 at 6:54 PM
Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance - Business WireCerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance - Business Wire
businesswire.com - May 4 at 6:54 PM
Blood Plasma Products market expecting to reach highest cagr till 2025: Takeda Pharmaceutical Company, Baxter International Inc., Innovative Research, Inc., Cerus Corporation, Octapharma AG, ADMA Biologics Inc., and ARTHREX INC. - Clark County BlogBlood Plasma Products market expecting to reach highest cagr till 2025: Takeda Pharmaceutical Company, Baxter International Inc., Innovative Research, Inc., Cerus Corporation, Octapharma AG, ADMA Biologics Inc., and ARTHREX INC. - Clark County Blog
clarkcountyblog.com - May 4 at 8:53 AM
DateCompanyBrokerageAction
3/25/2021MiMedx GroupHC WainwrightInitiated Coverage
5/10/2021SI-BONENeedham & Company LLCBoost Price Target
5/10/2021SI-BONEMorgan StanleyBoost Price Target
5/10/2021SI-BONECanaccord GenuityBoost Price Target
5/4/2021SI-BONETruist SecuritiesBoost Price Target
1/8/2021SI-BONEJMP SecuritiesBoost Price Target
6/15/2020SI-BONECantor FitzgeraldInitiated Coverage
1/25/2021Tactile Systems TechnologyBTIG ResearchBoost Price Target
11/13/2020Tactile Systems TechnologyOppenheimerUpgrade
4/6/2020Tactile Systems TechnologyPiper SandlerReiterated Rating
11/18/2019Tactile Systems TechnologyPiper Jaffray CompaniesInitiated Coverage
6/13/2019Tactile Systems TechnologyDougherty & CoInitiated Coverage
5/7/2019Tactile Systems TechnologyGuggenheimBoost Price Target
3/22/2019Tactile Systems TechnologyNorthland SecuritiesReiterated Rating
5/27/2020CerusStifel NicolausBoost Price Target
4/16/2020CerusStephensLower Price Target
8/3/2018CerusCowenSet Price Target
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.